Clinical Trial Update: PET Imaging of Neuroinflammation in Neurodegenerative Diseases Via a Novel Translocator Protein (TSPO) Radioligand [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating a novel TSPO radioligand for PET imaging of neuroinflammation in dementia was terminated, with results posted on May 1, 2024…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dementia

Snippet

Sponsor: National Institute of Mental Health (NIMH) | Conditions: Dementia | Phase 1 | Status: TERMINATED | Results posted: 2024-05-01